Evidence map›Paper›PMID 41355361›Full record

ArticleHuman vaccines & immunotherapeutics2025

Reporting profile of adverse events following DTaP-IPV/Hib pentavalent vaccine: A 13-year real-world surveillance data analysis.

Chao Zhang, Xiaoqi Liu, Liping Han, Jianyong Shen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chao ZhangInstitute of Immunization and Prevention, Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.
Xiaoqi LiuInstitute of Immunization and Prevention, Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.
Liping HanInstitute of Immunization and Prevention, Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.
Jianyong ShenInstitute of Immunization and Prevention, Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We performed a retrospective descriptive analysis of adverse events following immunization (AEFI) surveillance data to systematically analyze the epidemiological characteristics and temporal trends of AEFI with the DTaP-IPV/Hib pentavalent vaccine in Huzhou city from 2012 to 2024. The overall AEFI reporting rate was 19.67/10,000, showing a significant upward trend (

Indexed as

Adverse Drug Reaction Reporting SystemsDiphtheria-Tetanus-Pertussis VaccineDrug-Related Side Effects and Adverse ReactionsHaemophilus VaccinesPoliovirus Vaccine, InactivatedAdolescentAdultChildChild, PreschoolChinaFemaleHumansInfantMaleMiddle AgedRetrospective StudiesDiphtheria-Tetanus-Pertussis VaccineHaemophilus VaccinesPoliovirus Vaccine, InactivatedVaccines, Combinedadverse eventsadverse events following immunizationDTaP-IPV/Hibreporting ratevaccine safety

Identifiers

PMID41355361
PMCPMC12688269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.